Masa Lasica

7PUBLICATIONS
79CO-AUTHORS
Gene and molecular therapyHaematological tumoursLanguage documentation and descriptionAutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 22, 2026
Selinexor plus lenalidomide versus lenalidomide alone as maintenance therapy after autologous haematopoietic stem cell transplantation in newly diagnosed multiple myeloma: Results of the phase 3 ALLG MM23 (SeaLAND) trial.

|Sep 20, 2026
Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.

|Jul 07, 2026
Australasian chronic lymphocytic leukaemia consensus statement: 2026 update.

|Nov 23, 2024
Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.

Allison Barraclough, Catherine Tang, Masa Lasica

|Jun 17, 2024
Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance.

Masa Lasica, Mary A Anderson, Alex Boussioutas

|Sep 24, 2023
Chronic lymphocytic leukaemia Australasian consensus practice statement.

Mary A Anderson, Rory Bennett, Xavier Badoux

Pageof 2

Frequent Collaborators

3 joint publications

Constantine Tam

3 joint publications

Rosemary Harrup

2 joint publications

Richard Eek

2 joint publications

Dipti Talaulikar